Follicular stimulation for high tech pregnancies: are we playing it safe?
作者信息
Fishel S, Jackson P
机构信息
Department of Obstetrics and Gynaecology, University of Nottingham, Queen's Medical Centre.
出版信息
BMJ. 1989 Jul 29;299(6694):309-11. doi: 10.1136/bmj.299.6694.309.
Abstract
摘要
相似文献
1
Follicular stimulation for high tech pregnancies: are we playing it safe?高科技受孕中的卵泡刺激：我们这样做安全吗？
BMJ. 1989 Jul 29;299(6694):309-11. doi: 10.1136/bmj.299.6694.309.
2
Biological activity of hormones in preovulatory follicular fluid and serum of women undergoing ovarian stimulation.接受卵巢刺激的女性排卵前卵泡液和血清中激素的生物活性。
Dan Med Bull. 1997 Jun;44(3):257-73.
3
[Use of echography as the basic method for monitoring follicular development in stimulated cycles].[将超声检查用作刺激周期中卵泡发育监测的基本方法]
Akush Ginekol (Mosk). 1987 Sep(9):14-7.
4
Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.单剂量长效重组促卵泡激素（FSH-CTP，注射用重组人促卵泡激素α）诱导多个卵泡发育用于体外受精前的控制性卵巢刺激。
J Clin Endocrinol Metab. 2004 May;89(5):2062-70. doi: 10.1210/jc.2003-031766.
5
Follicular stimulation and ovarian cancer?
Hum Reprod. 1993 Jul;8(7):990-6. doi: 10.1093/oxfordjournals.humrep.a138215.
6
Effect of the short follicular phase on subsequent conception.卵泡期短对后续受孕的影响。
Gynecol Obstet Invest. 1992;34(3):180-3. doi: 10.1159/000292755.
7
Recruitment of multiple follicular development for in vitro fertilization in the presence of a viable intrauterine pregnancy.
Obstet Gynecol. 1987 Sep;70(3 Pt 2):498-9.
8
Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.卵泡晚期每日低剂量人绒毛膜促性腺激素刺激卵巢用于体外受精：一项前瞻性随机试验。
Fertil Steril. 2006 Oct;86(4):830-8. doi: 10.1016/j.fertnstert.2006.02.110. Epub 2006 Sep 11.
9
Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.在低反应者的微刺激方案中使用孕激素对优势卵泡进行控制性排卵。
Reprod Biol Endocrinol. 2017 Sep 5;15(1):71. doi: 10.1186/s12958-017-0291-0.
10
[Ovarian stimulation and follicular puncture risks].
Gynecol Obstet Fertil. 2009 Nov-Dec;37(11-12):926-33. doi: 10.1016/j.gyobfe.2009.06.007. Epub 2009 Oct 8.
引用本文的文献
1
Estimating the impact of bias in causal epidemiological studies: the case of health outcomes following assisted reproduction.估算因果流行病学研究中偏倚的影响：辅助生殖后健康结果的案例。
Hum Reprod. 2024 May 2;39(5):869-875. doi: 10.1093/humrep/deae053.
2
Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis.促排卵药物与卵巢癌：一项更新的系统评价和荟萃分析。
J Ovarian Res. 2023 Jan 24;16(1):22. doi: 10.1186/s13048-022-01084-z.
3
In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services.体外受精与乳腺和妇科癌症风险：以色列马卡比医疗保健服务的回顾性队列研究。
Fertil Steril. 2013 Apr;99(5):1189-96. doi: 10.1016/j.fertnstert.2012.12.029. Epub 2013 Jan 30.
4
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.荷兰大样本队列研究中体外受精卵巢刺激后交界性和浸润性卵巢肿瘤的风险
Hum Reprod. 2011 Dec;26(12):3456-65. doi: 10.1093/humrep/der322. Epub 2011 Oct 26.
5
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort.促排卵药物与癌症风险：对一个英国队列的长期随访
Br J Cancer. 2009 Jun 2;100(11):1824-31. doi: 10.1038/sj.bjc.6605086. Epub 2009 May 12.
6
Safety of drugs used in assisted reproduction techniques.辅助生殖技术中使用药物的安全性。
Drug Saf. 2005;28(6):513-28. doi: 10.2165/00002018-200528060-00004.
7
The student and the ovum: the lack of autonomy and informed consent in trading genes for tuition.学生与卵子：以基因换取学费过程中自主权与知情同意权的缺失
Reprod Biol Endocrinol. 2004 Jul 12;2:56. doi: 10.1186/1477-7827-2-56.
8
Follicular stimulation: is it safe?
BMJ. 1989 Oct 7;299(6704):916.
9
Follicular stimulation and ovarian cancer.卵泡刺激与卵巢癌
BMJ. 1989 Sep 16;299(6701):740. doi: 10.1136/bmj.299.6701.740-b.
10
Should fertile people have access to in vitro fertilisation?
BMJ. 1990 Apr 21;300(6731):1078. doi: 10.1136/bmj.300.6731.1078-a.
本文引用的文献
1
Sulphur dioxide in foods and beverages: its use as a preservative and its effect on asthma.食品和饮料中的二氧化硫：其作为防腐剂的用途及其对哮喘的影响。
Br J Dis Chest. 1980 Apr;74(2):128-34. doi: 10.1016/0007-0971(80)90023-6.
2
Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report.
Br J Obstet Gynaecol. 1982 Nov;89(11):962-4. doi: 10.1111/j.1471-0528.1982.tb05067.x.
3
Massive hyperstimulation and borderline carcinoma of the ovary. A possible association.
Acta Obstet Gynecol Scand. 1982;61(3):261-3. doi: 10.3109/00016348209156568.
4
Regulation of carcinogen metabolism in the rat ovary by the estrous cycle and gonadotropin.
Science. 1983 Mar 25;219(4591):1437-8. doi: 10.1126/science.6681915.
5
Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis.
J Natl Cancer Inst. 1983 Oct;71(4):717-21.
6
Effects of carcinogen and/or mutagen on normal and gonatotropin-primed ovaries of mice.
Int J Cancer. 1981 Jul 15;28(1):105-10. doi: 10.1002/ijc.2910280118.
7
Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin.使用自然月经周期或用枸橼酸氯米芬及人绝经期促性腺激素进行卵泡刺激后的体外受精着床、流产及分娩情况。
J In Vitro Fert Embryo Transf. 1985 Sep;2(3):123-31. doi: 10.1007/BF01131498.
8
Hyperstimulation: the need for cryopreservation of embryos.
Hum Reprod. 1988 Oct;3 Suppl 2:53-7. doi: 10.1093/humrep/3.suppl_2.53.
9
Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.用促黄体生成素释放激素激动剂布舍瑞林治疗后体外受精情况的改善
Br Med J (Clin Res Ed). 1988 Jun 25;296(6639):1765-8. doi: 10.1136/bmj.296.6639.1765.
10
Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report.促性腺激素治疗体外受精导致患者卵巢过度刺激并发卵巢癌：一例报告
J In Vitro Fert Embryo Transf. 1987 Apr;4(2):126-8. doi: 10.1007/BF01555453.
Zotero 插件